Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Verisante Technology, Inc. (OTC: VRSEF).

Full DD Report for VRSEF

You must become a subscriber to view this report.

Recent News from (OTC: VRSEF)

Verisante Announces Signing of Definitive Agreement for RTO with Myanmar based SIM Co. Ltd.
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2018) - Verisante Technology, Inc. (TSXV: VRS) (the "Company" or "Verisante"), is pleased to announce it has entered into a Definitive Agreement with Myanmar based SIM Co. Ltd. ("SIM") dated June 30, 2018, whereby VRS shall acquire all...
Source: Newsfile
Date: July, 09 2018 10:00
Verisante Announces LOI for RTO with Myanmar based SIM Co. Ltd.
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2018) - Verisante Technology, Inc. (TSXV: VRS) (OTCQX: VRSEF) (the "Company" or "Verisante"), is pleased to announce it has entered into a Letter of Intent with Myanmar based SIM Co. Ltd. ("SIM") dated April 17, 2018, whereby the parti...
Source: Newsfile
Date: April, 23 2018 16:41
Verisante Technology, Inc.: Unaware of Any Material Change
Vancouver, British Columbia--(Newsfile Corp. - January 19, 2018) - At the request of IIROC, Verisante Technology, Inc. (TSXV: VRS) ("Verisante" or the "Company") wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for...
Source: Newsfile
Date: January, 19 2018 12:52


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VRSEF.

About Verisante Technology, Inc. (OTC: VRSEF)

Logo for Verisante Technology, Inc. (OTC: VRSEF)

Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer. Our exclusive platform technology allows us to develop and offer a range of compact, non invasive cancer detection devices that offer immediate results for many of the most common cancers including skin, lung, gastrointestinal, cervical and colorectal.




Current Management

  • Thomas Braun / President, CEO
  • Anna Trinh / CFO, Corporate Counsel
  • Karen Boodram /
  • Thomas Braun /
  • Branko Palcic /
  • Jake Thiessen /

Current Share Structure

  • Market Cap: $1,180,426 - 03/16/2018
  • Issue and Outstanding: 91,505,888 - 09/30/2015
  • Float: 45,020,640 - 12/31/2012


Daily Technical Chart for (OTC: VRSEF)

Daily Technical Chart for (OTC: VRSEF)

Stay tuned for daily updates and more on (OTC: VRSEF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: VRSEF)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VRSEF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of VRSEF and does not buy, sell, or trade any shares of VRSEF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: